Ascend Laboratories Ltd — licence 3-002524, currently licensed, last inspection rating C (2024-04-25).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02514532 | AG-RASAGILINE | ANGITA PHARMA INC. | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02514540 | AG-RASAGILINE | ANGITA PHARMA INC. | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02404680 | APO-RASAGILINE | APOTEX INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02404699 | APO-RASAGILINE | APOTEX INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02489139 | ASN-RASAGILINE | ASCEND LABORATORIES LTD | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02284642 | AZILECT | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02284650 | AZILECT | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02491974 | JAMP RASAGILINE | JAMP PHARMA CORPORATION | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02491982 | JAMP RASAGILINE | JAMP PHARMA CORPORATION | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02533723 | MINT-RASAGILINE | MINT PHARMACEUTICALS INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02533731 | MINT-RASAGILINE | MINT PHARMACEUTICALS INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02418444 | TEVA-RASAGILINE | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02418436 | TEVA-RASAGILINE | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |